» Articles » PMID: 25540270

Survey of Immunological Features of the Alpha-like Proteins of Streptococcus Agalactiae

Overview
Date 2014 Dec 26
PMID 25540270
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Nearly all Streptococcus agalactiae (group B streptococcus [GBS]) strains express a protein which belongs to the so-called alpha-like proteins (Alps), of which Cα, Alp1, Alp2, Alp3, Rib, and Alp4 are known to occur in GBS. The Alps are chimeras which form mosaic structures on the GBS surface. Both N- and C-terminal stretches of the Alps possess immunogenic sites of dissimilar immunological specificity. In this review, we have compiled data dealing with the specificity of the N- and C-terminal immunogenic sites of the Alps. The majority of N-terminal sites show protein specificity while the C-terminal sites show broader cross-reactivity. Molecular serotyping has revealed that antibody-based serotyping has often resulted in erroneous Alp identification, due to persistence of cross-reacting antibodies in antisera for serotyping. Retrospectively, this could be expected on the basis of sequence analysis results. Some of the historical R proteins are in fact Alps. The data included in the review may provide a basis for decisions regarding techniques for the preparation of specific antisera for serotyping of GBS, for use in other approaches in GBS research, and for decision making in the context of GBS vaccine developments.

Citing Articles

Diversity in Naturally Acquired Immunity to Group B Streptococcus: A Comparative Study of Women From Bangladesh, Malawi, and the United Kingdom.

Khandaker S, Sharma S, Hall T, Lim S, Lehtonen J, Leung S J Infect Dis. 2024; 231(2):e456-e467.

PMID: 39692506 PMC: 11841642. DOI: 10.1093/infdis/jiae607.


Group B streptococcal infections in pregnancy and early life.

Manuel G, Twentyman J, Noble K, Eastman A, Aronoff D, Seepersaud R Clin Microbiol Rev. 2024; 38(1):e0015422.

PMID: 39584819 PMC: 11905376. DOI: 10.1128/cmr.00154-22.


Strain-level genomic analysis of serotype, genotype and virulence gene composition of group B streptococcus.

Zeng Z, Li M, Zhu S, Zhang K, Wu Y, Zheng M Front Cell Infect Microbiol. 2024; 14:1396762.

PMID: 39569407 PMC: 11576427. DOI: 10.3389/fcimb.2024.1396762.


Bioinformatics analysis to design a multi-epitope mRNA vaccine against S. agalactiae exploiting pathogenic proteins.

Barazesh M, Abbasi M, Mohammadi M, Nasiri M, Rezaei F, Mohammadi S Sci Rep. 2024; 14(1):28294.

PMID: 39550419 PMC: 11569170. DOI: 10.1038/s41598-024-79503-y.


Group B Streptococcus Infections in Non-Pregnant Adults, Italy, 2015-2019.

Imperi M, Gherardi G, Alfarone G, Creti R Pathogens. 2024; 13(9).

PMID: 39338998 PMC: 11434888. DOI: 10.3390/pathogens13090807.


References
1.
Bevanger L, Kvam A, Maeland J . A Streptococcus agalactiae R protein analysed by polyclonal and monoclonal antibodies. APMIS. 1995; 103(10):731-6. DOI: 10.1111/j.1699-0463.1995.tb01430.x. View

2.
Baron M, Filman D, Prophete G, Hogle J, Madoff L . Identification of a glycosaminoglycan binding region of the alpha C protein that mediates entry of group B Streptococci into host cells. J Biol Chem. 2007; 282(14):10526-36. DOI: 10.1074/jbc.M608279200. View

3.
Bohnsack J, Whiting A, Martinez G, Jones N, Adderson E, Detrick S . Serotype III Streptococcus agalactiae from bovine milk and human neonatal infections. Emerg Infect Dis. 2004; 10(8):1412-9. PMC: 3320405. DOI: 10.3201/eid1008.030917. View

4.
Kling D, Gravekamp C, Madoff L, Michel J . Characterization of two distinct opsonic and protective epitopes within the alpha C protein of the group B Streptococcus. Infect Immun. 1997; 65(4):1462-7. PMC: 175154. DOI: 10.1128/iai.65.4.1462-1467.1997. View

5.
Gravekamp C, Horensky D, Michel J, Madoff L . Variation in repeat number within the alpha C protein of group B streptococci alters antigenicity and protective epitopes. Infect Immun. 1996; 64(9):3576-83. PMC: 174266. DOI: 10.1128/iai.64.9.3576-3583.1996. View